Selective Accumulation of Boron-conjugated Liposomes Composed Of Dimyristoylphosphatidylcholine to B16F10 Murine Melanoma Cells in Relation to Fluidity of Cell Membranes.
S. Kasaoka, A. Kunisawa, Y. Okishima, Y. Tanaka, H. Yoshikawa, Y. Sanada1, Y. Sakurai, H. Tanaka and S. Masunaga. KURRI PROGRESS REPORT. 2018. 7.

溶出試験液中で不安定な薬物の溶出試験方法,
長田俊治, 伊波綾乃, 竹下亜沙未, 東 昂佑, 馬場実佳子, 田中佑典, 医学と薬学, 2018, 75巻, 1051-1060.

Combined effects of the drug distribution and mucus diffusion properties of self-microemulsifying drug delivery systems on the oral absorption of fenofibrate.
Sunazuka Y, Ueda K, Higashi K, Tanaka Y, Moribe K. Int J Pharm. 2018, 546:263-271.

In vivo analysis of supersaturation/precipitation/absorption behavior after oral administration of pioglitazone hydrochloride salt; determinant site of oral absorption.
Tanaka Y, Sugihara M, Kawakami A, Imai S, Itou T, Murase H, Saiki K, Kasaoka S, Yoshikawa H. Eur J Pharm Sci. 2017, 106:431-438.

In vivo evaluation of supersaturation/precipitation/re-dissolution behavior of cinnarizine, a lipophilic weak base, in the gastrointestinal tract: the key process of oral absorption.
Tanaka Y, Kawakami A, Nanimatsu A, Horio M, Matsuoka J, Wada T, Kasaoka S, Yoshikawa H. Eur J Pharm Sci. 2017. 1:464-471.

Effect of Absorption Behavior of Solubilizers on Drug Dissolution in the Gastrointestinal Tract: Evaluation Based on In Vivo Luminal Concentration-Time Profile of Cilostazol, a Poorly Soluble Drug, and Solubilizers.
Tanaka Y, Kubota A, Matsuo A, Kawakami A, Kamizi H, Mochigoe A, Hiramachi T, Kasaoka S, Yoshikawa H, Nagata S. J Pharm Sci. 2016. 105:2825-31.

Impact of Luminal Fluid Volume on the Drug Absorption After Oral Administration: Analysis Based on In Vivo Drug Concentration-Time Profile in the Gastrointestinal Tract.
Tanaka Y, Goto T, Kataoka M, Sakuma S, Yamashita S. J Pharm Sci. 2015. 104:3120-7.